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Abstract
Phase changes in Bacteroides fragilis, a member of the human colonic microbiota, mediate
variations in a vast array of cell surface molecules, such as capsular polysaccharides and
outer membrane proteins through DNA inversion. The results of the present study show
that outer membrane vesicle (OMV) formation in this anaerobe is also controlled by DNA
inversions at two distantly localized promoters, IVp-I and IVp-II that are associated with
extracellular polysaccharide biosynthesis and the expression of outer membrane proteins.
These promoter inversions are mediated by a single tyrosine recombinase encoded by
BF2766 (orthologous to tsr19 in strain NCTC9343) in B. fragilis YCH46, which is located
near IVp-I. A series of BF2766 mutants were constructed in which the two promoters were
locked in different configurations (IVp-I/IVp-II = ON/ON, OFF/OFF, ON/OFF or OFF/ON).
ON/ON B. fragilismutants exhibited hypervesiculating, whereas the other mutants formed
only a trace amount of OMVs. The hypervesiculating ON/ON mutants showed higher resis-
tance to treatment with bile, LL-37, and human β-defensin 2. Incubation of wild-type cells
with 5% bile increased the population of cells with the ON/ON genotype. These results indi-
cate that B. fragilis regulates the formation of OMVs through DNA inversions at two distantly
related promoter regions in response to membrane stress, although the mechanism under-
lying the interplay between the two regions controlled by the invertible promoters remains
unknown.
Introduction
The gut is the part of the human body that is most densely populated with diverse microorgan-
isms. The intestinal microbiota comprises diverse prokaryotic, eukaryotic and archaeal species
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whose populations may reach hundreds of trillions of cells. The microbial composition
markedly differs throughout the intestinal tract [1], indicating that the human gut harbors
unique microbe-microbe and host-microbe interactions that depend on the location in the
digestive tract. Therefore, intestinal microbes must adapt to the environmental changes in their
habitats including changes in nutrient availability and the levels of antimicrobial substances
produced by host immunity. Because microbial adaptations reflect the characteristics of their
habitats, identifying the adaptation mechanisms of gut microbes will increase the current
understanding of the intestinal environment. Because the cell surface is the first point of con-
tact with host components, cell surface adaptation is particularly important for gut bacteria to
sense and survive various environmental stimuli [2].
Bacteroides represent a major component of the human gut microbiota [3]. Analysis of the
Bacteroides genome revealed that these bacteria utilize a large set of dietary polysaccharides
and produce many types of capsular polysaccharides on their cell surfaces [4–7]. B. fragilis can
cause septicemia, appendicitis, and abdominal abscesses in humans [8]. Capsular polysaccha-
ride A (PS A) is the most important virulence factor of B. fragilis in the induction of peritoneal
abscesses [9]. PS A reportedly enhances the function of Foxp3+ regulatory T cells (Tregs) in the
colonic lamina propria [10–12]. This finding suggests that B. fragilis produces PS A not only to
evade the host immune system but also to actively modulate host physiological functions, prob-
ably contributing to microenvironmental homeostasis in the human colonic mucosa. In addi-
tion, Shen et al. reported that this immunomodulatory PS A is packaged into outer membrane
vesicles (OMVs) and transported to host dendritic cells (DCs), resulting in the programming
of DCs via a toll-like receptor 2 (TLR2) signaling pathway to induce CD4+, Foxp3+ Treg cells
[13]. This study also revealed that PS A-containing OMVs protect mice from experimental
colitis induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS).
OMVs are produced by many Gram-negative bacteria. They participate in infection in a
variety of ways, such as by delivering bacterial components (e.g., heat-labile enterotoxins) to
host cells infected with enterotoxigenic Escherichia coli [14] and by delivering quorum-sensing
signaling molecules in Pseudomonas aeruginosa [15]. In addition, OMVs play a role in inter-
kingdom communication [16]. However, the mechanism underlying OMV formation remains
unknown.
B. fragilis regulates the expression of PS A and six other capsular polysaccharides via phase-
variable promoter inversions [17]. B. fragilis DNA inversions have also been associated with
variable expression of outer membrane proteins in the SusC/SusD family [18], surface proteins
associated with the autoaggregative phenotype [19], and high-molecular-weight extracellular
polysaccharide (EPS) [20]. These phase variations are probably associated with the modulation
of host immunity, nutrient uptake, and biofilm formation, respectively. Three master DNA
invertases that globally control promoter inversions at many distant regions have been identi-
fied in B. fragilis: Mpi inverts 13 regions, seven of which are PS promoters [21]; Tsr0667 is
responsible for shufflon-type multiple DNA inversions at three SusC/SusD outer membrane
gene clusters and nine other invertible regions [18]; and Tsr19 (corresponding to the
BF2766-encoded DNA invertase in B. fragilis YCH46) inverts the local and distant promoters
(Fig 1A) that confer the large-capsule phenotype on this species [20, 22]. The BF2766-regulated
invertible regions are unique in that the local promoter (designated as IVp-I in Fig 1A) shifted
in the OFF orientation relative to the three downstream EPS biosynthesis genes in cultured
media and in a majority of tested human feces samples [20], which indicates that continuous
expression of this EPS is not essential for colon colonization by B. fragilis.
In the present study, the two BF2766-regulated invertible promoters of B. fragilis YCH46
were further analyzed to determine the role of their associated proteins in surface structure
modification. The results indicated that OMV formation in B. fragilis is attributed to the two
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BF2766-regulated regions. Vesiculating B. fragilis cells exhibited increased resistance to bile
and certain types of human defensins. The data presented here may enhance the current
understanding of the genetic basis of OMV formation and the role (s) of these vesicles in mutu-
alistic colonization by B. fragilis.
Results
The BF2766-encoded DNA invertase mediates local and distant
promoter inversions
The B. fragilis genome contains at least eight capsular polysaccharide biosynthesis loci (PS
loci). Among these, seven include invertible promoters, which enable the bacteria to alter the
surface glycan in a phase-variable manner [17]. These PS promoter inversions are mediated
by a single serine recombinase, Mpi. The B. fragilis gene that encodes Mpi co-localizes with a
tyrosine recombinase gene (BF2766 in strain YCH46, which corresponds to tsr19 in strain
NCTC9343) in a head-to-head orientation (Fig 1A). The BF2766 gene reportedly regulates pro-
moter inversions in two regions: the immediate downstream promoter of an extracellular poly-
saccharide (EPS) operon and a gene cluster that includes a lipoprotein gene [20, 22]. Detailed
information about the genetic composition of these regions is summarized in S1 Table. In the
present study, these two invertible promoters are designated IVp-I and IVp-II, respectively.
The IVp-I inversion has been associated with high-molecular-weight EPS production in B.
fragilis NCTC9343, but the function of IVp-II remains uncharacterized [20]. To further char-
acterize the IVp-I/IVp-II-related B. fragilis phenotype, BF2766, which encodes the master
Fig 1. Genetic disruption of BF2766 to lock the IVp-I/IVp-II orientation. (A) An open-reading-frame map
of the regions containing the BF2766-regulated invertible promoters IVp-I and IVp-II. Thempi gene encodes
a master recombinase that controls seven PS promoter inversions. The genes downstream of IVp-I
(BF2767-BF2769) are associated with extracellular polysaccharide production. IVp-II is located just upstream
of the seven-gene cluster (BF3397-BF3403). The IVp-II orientation does not influence the transcription of the
upstream groES/EL chaperonin genes. Detailed information about the genes shown in this panel is
summarized in S1 Table. Gray arrowheads: inverted repeat sequences (IRs). Black arrowheads: promoter
orientation. (B) PCR-based confirmation of a 676-bp internal deletion of BF2766. The four mutants with
different genotypic combinations of IVp-I/IVp-II orientation were used for the following analyses. (C)
Schematic of the primer design to detect IVp-I/IVp-II orientations. (D) BF2766 mutants showing the different
IVp-I/IVp-II-locked patterns. F and R indicate the primer pair shown in panel C. In a wild-type sample, PCRs
with both the F and R primers produced bands of the expected size (indicated on the right side), showing that
IVp-I/IVp-II promoter inversion occurs in vitro. The locked patterns of IVp-I/IVp-II in the BF2766 mutants are
indicated above the lane. For example, ON/ON indicates that both promoters are locked ON relative to
downstream genes. Plasmid complementation of the mutants with intact BF2766 restored IVp-I/IVp-II
promoter inversion. The IVp-I OFF genotype was prevalent in the wild type, but plasmid complementation
abrogated this deviation.
doi:10.1371/journal.pone.0148887.g001
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recombinase for these promoters, was deleted in strain YCH46 (Fig 1B). The BF2766 deletion
abrogated DNA inversions at both IVp-I and IVp-II. Among the 96 mutant colonies screened,
we obtained only one genotype, in which the IVp-I/IVp-II promoters were locked in the OFF/
ON orientation (IVp-I being OFF and IVp-II being ON) relative to downstream genes, indicat-
ing that the OFF/ON genotype was predominant in laboratory broth culture.
To determine the effect of IVp-I/IVp-II promoter inversions on B. fragilis physiology, four
locked mutants (IVp-I/IVp-II locked in the ON/ON, ON/OFF, OFF/ON or OFF/OFF orienta-
tion relative to downstream genes) were constructed. These four mutants were obtained by
complementing the OFF/ON mutant with a plasmid harboring BF2766 and then curing the
plasmid in nonselective medium (Fig 1D). The PCR-based determination of the resultant ori-
entations showed that the IVp-I-ON population (indicated by “F”) was smaller than the IVp-
I-OFF population (indicated by “R”) in wild-type cells. No differences were observed in the fre-
quencies of the IVp-II orientation. The deviations in the IVp-I orientation disappeared when
the BF2766 mutant was complemented with a plasmid encoding BF2766, which suggests that
BF2766 expression is suppressed in wild-type cells or that a regulatory mechanism controls
IVp-I orientation.
It has been reported in NCTC9343 that the number of inverted repeat sequences (IRs)
between the promoter and the downstream genes is inversely correlated with the transcrip-
tional levels of the EPS biosynthesis operon downstream of IVp-I [20]. Consequently, the tsr19
(ortholog of BF2766) mutant with a single IR between the promoter and the downstream genes
showed increased EPS production, and these bacteria did not pelleted after centrifugation,
whereas mutants with two or three IRs generated relatively compact pellets. Both of the locked
IVp-I ON BF2766 mutants generated in the present study have two IRs between the promoter
and downstream gene (S1 Fig).
Cell surface morphology of the four types of IVp-I/IVp-II-locked mutants
As shown in Fig 2A, ON/ON mutant cells sedimented more rapidly than other IVp-I/IVp-II-
locked mutants. This rapid cell sedimentation rate indicated that the ON/ON mutant has a
unique phenotype that is associated with autoaggregation. Scanning electron microscopy
(SEM) showed that the cell surface of the ON/ONmutant was markedly different from that of
the other locked mutants and that the ON/ON cells displayed a large number of surface vesicle
Fig 2. Orientation-specific phenotypes of BF2766mutant B. fragilis cells with respect to IVp-I/IVp-II.
(A) The four types of IVp-I/IVp-II-locked mutants were anaerobically cultured in GAM broth overnight. Each
culture was mixed to homogeneity and grown in an anaerobic chamber. Periodically, cell sedimentation was
visually compared. ON/ON cells sank to the bottom faster than the other three genotypes, generating a more
compact cell pellet. The promoter patterns are indicated above the tubes. (B) Scanning electron micrographs
of wild-type and mutant cells. Plasmid-complemented BF2766 mutant cells (pVAL2766) were also examined.
The ON/ON-locked mutant produced a large number of vesicle structures on the cell surface. Bar: 2 μm.
doi:10.1371/journal.pone.0148887.g002
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structures (Fig 2B). Transmission electron microscopy (TEM) also demonstrated that the ON/
ONmutant produces a large number of 20-50-nm OMVs whereas OMVs were observed in
only a small number of wild-type and other mutant cells (Fig 3). The plasmid complementation
of ON/ONmutant with BF2766 decreased OMV production. Together, these results suggested
that the cooperative action of IVp-I and IVp-II regulates the gene products involved in OMV
formation in B. fragilis.
To examine whether the hypervesiculation phenotype was strain-specific, we engineered the
ON/ON genotype in NCTC9343. SEM analysis demonstrated that hypervesiculation was also
observed in ON/ON genotypes derived from NCTC9343 (S2 Fig).
Role of IVp-I/IVp-II on downstream gene expressions
A previous study based on the xylE reporter assay showed that IVp-II has no effect on down-
stream gene expression [20]. However, the data obtained in the present study indicated that
IVp-II promoter orientation is associated with OMV production. Thus, qPCR analysis of the
IVp-I and IVp-II downstream genes was performed on the four locked mutants. As shown in
Fig 4A, gene expression in both regions depended on the orientation of IVp-I and IVp-II. The
expression of BF2767 and BF2769 (the first and last genes of the EPS production operon) was
induced only when IVp-I was ON relative to these genes. The transcriptional levels of BF2767
and BF2769 in the parental strain were lower than in the IVp-I-ON mutants, consistently with
the results of the PCR analysis (Fig 1D), in which the population of IVp-I-ON genotypes was
low in in vitro growth media. Similarly, IVp-II was necessary for the transcription of BF3397
(the gene immediately downstream of IVp-II). As reported [22], the IVp-II promoter did not
have a role in the expression of the upstream groES/EL operon.
Interestingly, the expression of the genes downstream of IVp-II was much higher in ON/
ON cells than in OFF/ON cells (with 25- and 40-fold increases in BF3397 and BF3403 expres-
sion, respectively). This effect was not observed for BF2767 and BF2769, for which there was
no observed difference between the ON/ON and ON/OFF genotypes. Therefore, the IVp-I-reg-
ulated genomic region might have a regulatory role in IVp-II-regulated gene expression. To
examine this hypothesis, we deleted a region, beginning with the genes immediately down-
stream of IVp-I (BF2767) and extending to just upstream of the upxY genes (BF2774) in the
capsular polysaccharide biosynthesis locus (PS-7), in the ON/ON mutant (Fig 1A). However,
these deletions had no effect on the expression levels of IVp-II-regulated genes (Fig 4B), the
Fig 3. Transmission electronmicrograph of BF2766mutantB. fragilis cells. B. fragilis cells were fixed
with 2% glutaraldehyde/PBS and analyzed by TEM to observe OMVs. OMVs (arrows) were observed in wild-
type B. fragilis (panel a). The ON/ON locked mutant (panel b) produced a large number of OMVs that formed
clusters or chains. Plasmid complementation of the ON/ONmutant with intact BF2766 decreased OMV
production to wild-type levels (panel d). The level of OMV production was similar among the OFF/ON (panel
c), OFF/OFF (panel e), and ON/OFF (panel f) mutants. Bar: 0.1 μm.
doi:10.1371/journal.pone.0148887.g003
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expression levels of BF3397 and BF3403 remained similar to those detected in the original ON/
ONmutant.
The IVp-I promoter region was subsequently deleted from the ON/ON mutant. This dele-
tion reduced the expression of IVp-II-regulated genes to levels similar to those in the OFF/ON
genotype (Fig 4B). Bayley et al. reported that an alteration of the Bacteroides promoter
sequence at -7 (TAnnTTTG) to TAnnAAAC resulted in the loss of promoter activity [23].
When this same alteration was introduced into IVp-I through site-directed mutagenesis, the
enhancement effect on IVp-II activity was abolished (Fig 4C). These results suggest that IVp-I
activity is necessary for the overexpression of IVp-II-regulated genes.
DNA microarray analysis was performed with the four locked mutants to identify genetic
regions whose alterations in expression were specifically associated with the ON/ON mutant.
Only 11 genes were differentially expressed (>4-fold change) in the ON/ON mutant (Fig 4D).
As shown in S2 Table, all of the genes were upregulated. Notably, ON/ON-specific expression
was limited to the IVp-II-related region (BF3397-BF3403, BF3406-BF3407 and BF3410), with
Fig 4. Orientation-specific unique transcriptional regulation by invertible IVp-I/IVp-II. (A) The
expression of EPS biosynthesis genes (represented as BF2767 and BF2769) and a gene cluster
(represented as BF3397 and BF3403) were dependent on IVp-I and IVp-II, respectively. The transcriptional
level of the IVp-II-regulated gene cluster in the hypervesiculating mutant (ON/ON) was increased 25- to
40-fold over that of the OFF/ONmutant. (B) IVp-I was required for the full expression of the gene cluster
downstream of IVp-II. A variety of deletions were generated within the EPS production locus or at the IVp-II-
regulated gene cluster in the hypervesiculating mutant (ON/ON). Only the deletion of the IVp-I-containing
invertible DNA region affected the expression of IVp-II-regulated genes. (C) The effects of IVp-I activity and
IVp-I-related IRs on IVp-II activity. IVp-I activity was attenuated after replacing the -7 sequence (TAnnTTTG is
the Bacteroides consensus promoter sequence at -7) with an inactive form (TAnnAAC) by using site-directed
mutagenesis. Two IRs were present between IVp-I and BF2767 in the ON/ONmutant obtained in this study.
These IRs and the entire invertible fragment containing IVp-I were deleted to examine the role of these
elements in IVp-II activity. (D) Venn diagram comparing differentially expressed genes in B. fragilismutants
with different IVp-I/IVp-II orientations. The number of differentially expressed genes (> 4-fold change) in each
genotype was compared with the ON/ON genotype. The expression levels of 11 genes were specifically
elevated in the ON/ONmutant (S2 Table).
doi:10.1371/journal.pone.0148887.g004
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the exception of BF4531. As shown in Fig 4C, genetic disruption of BF3407 (encoding an extra-
cytoplasmic function (ECF) sigma factor) in the ON/ON background did not change the
expression of BF3397 (the gene immediately downstream of IVp-II). These results indicate
that the genetic region that is responsible for the hypervesiculation phenotype observed in ON/
ONmutants is restricted to IVp-I and IVp-II-regulated loci.
Both EPS and IVp-II-regulated gene products are required for OMV
production
Deletions of IVp-I-related genes were then examined in the ON/ON background. Deletion of
the EPS production gene, BF2769 (encoding a tyrosine protein kinase) resulted in drastically
reduced OMV production (S3 Fig). Plasmid complementation of this mutant with intact
BF2769 restored OMV production to a level similar to that observed in the parental ON/ON
mutant. In contrast, OMV production was not affected by the deletion of BF2771, which is
located outside the EPS production operon.
Next, the roles of IVp-II-regulated genes in OMV production were examined. As shown in
Fig 5A, deletion of all the IVp-II-regulated genes (BF3397-BF3403) in the ON/ON background
abrogated vesiculation, and almost all of the cells exhibited a smooth cell surface. Plasmid com-
plementation of this mutant with a fragment containing BF3397-BF3403 resulted in an
approximately two fold increase in OMVs over that of the parental ON/ON mutant when
OMV production was quantified according to the protein content in culture supernatants
(Fig 5B).
Together, these data indicate that the high OMV production in B. fragilis is induced by the
cooperative action of gene products encoded by the IVp-I- and IVp-II-regulated regions and
that the overexpression of IVp-II-regulated genes is an essential part of the process.
Proteomic analysis of OMVs
The proteins in outer membrane and OMV fractions of ON/ON mutant of B. fragilis YCH46
were prepared as described by Elhemawy et al. [24] and separated by SDS-PAGE (Fig 6A). The
Fig 5. The role of IVp-II-regulated genes in B. fragilisOMV formation. (A) SEM was used to compare
OMV formation. The IVp-II-regulated gene cluster was entirely (Δ3397–3403) or partially (only BF3403, the
last gene of the cluster) deleted in the ON/ON genetic background of B. fragilis YCH46. Bar: 1 μm. (B)
Comparison of OMV production. OMV production was quantified by measuring the protein content of culture
supernatants. The graph indicates OMV production relative to that of the ON/ON (Δ3397–3403) mutant. The
data are expressed as means ± standard deviation. The bars labeled with different letters indicate significant
differences at p < 0.05.
doi:10.1371/journal.pone.0148887.g005
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protein profiles in OMVs were different from those in outer membrane, indicating the mecha-
nisms for sorting and exclusion of proteins into OMVmust exist in B. fragilis.
The ON/ON mutant derivative, in which BF3397 protein was engineered to be produced as
C-terminal FLAG tag fusion protein, was separated into whole cell, cytoplasmic, outer mem-
brane and OMV fractions. The proteins in each fraction were separated by SDS-PAGE, transfer
to PVDF membrane, and then blotted with anti-FLAG antibody. As shown in Fig 6B, BF3397
was localized in outer membrane and OMV fractions. Interestingly, the size of BF3397 was dif-
ferent in outer membrane and OMV fractions. BF3397 in OMV fraction was smaller than that
in outer membrane fraction. Because FLAGtag was fused to C-terminal end, BF3397 in OMVs
was predicted to be N-terminally processed. This processed form of BF3397 was enriched in
the OMVs.
Physiological roles of OMV production in B. fragilis
Gram-negative bacteria produce OMVs in response to membrane stress. Pumbwe et al.
reported that B. fragilis increased its OMV production when exposed to bile, indicating that
OMV formation is an adaptation for bile resistance [25]. Therefore, we monitored the popula-
tion levels of cells with IVp-I-ON or IVp-II-ON genotypes by using orientation-specific qPCR
in culture media with or without bile acid. Because the physiological bile concentration in the
human gut ranges from 0.1% to 1.3% [26, 27], B. fragilis YCH46 cells were treated with 1.0% or
5.0% bile (final concentration). B. fragilis YCH46 showed growth in medium containing 1%
bile that was comparable to its growth in bile-free medium (Fig 7A). Even in the presence of
5% bile, B. fragilis grew to an OD600 of nearly 1.0 within 8 h, although the lag phase was appar-
ently prolonged. Analysis by qPCR with DNA extracted from mid-log-phase cultures (5–6 h
point in Fig 7A) with and without bile showed that exposure to bile increased the number of
cells with the IVp-I-ON genotype in a dose-dependent manner (3.78- and 10.8-fold increase
with 1.0% and 5.0% bile exposure, respectively), whereas no significant effect was observed on
the population levels of cells with an IVp-II-ON genotype (Fig 7B). In accord with these find-
ings, the expression levels of BF2767 (IVp-I-regulated) and BF3397 and BF3403 (both IVp-II-
regulated) were elevated when the cells were exposed to 5.0% bile (Fig 7C). Furthermore, OMV
Fig 6. Proteomic analysis of OMVs purified fromON/ONmutant B. fragilis cells. (A) SDS-PAGE
patterns of outer membrane (OM) and OMV fractions. (B) Localization of FLAGtag-fused BF3397 protein.
One micrograms of the each purified fraction was separated by SDS-PAGE and BF3397 localization was
determined byWestern blotting with anti-FLAGtaq antibody. WC, whole cell; CP, cytoplasmic fraction; OM,
outer membrane fraction; and OMV, outer membrane vesicle fraction.
doi:10.1371/journal.pone.0148887.g006
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production based on the protein concentration in culture supernatants was increased 7-fold
after exposure to 5.0% bile than in cells without bile exposure (Fig 7D).
To further confirm the response of IVp-I- and IVp-II-regulated genes to bile, we monitored
the intracellular level of BF3397 by using a recombinant protein fused to a C-terminal FLAG
tag (Fig 7E). Following cultivation with or without 5% bile, the level of the BF3397-encoded
protein was quantified by Western blotting with an anti-FLAG antibody. As shown in Fig 7F,
the level of the BF3397-encoded membrane protein in wild-type cells increased in response to
bile exposure, whereas no increase was observed in the OFF/ON mutant. As shown in Fig 6, N-
terminally processed BF3397 (indicated by arrowhead), which was specifically localized in
OMVs, was observed in wild type cells exposed to bile as well as in ON/ON mutant. Interest-
ingly, the protein level was also increased in the ON/ON-locked mutant, suggesting that bile
exposure induces another regulatory mechanism for BF3397 protein production.
Resistance to antimicrobial substances
As described above, bile exposure increased the population level of the ON/ON genotype,
which led to the overexpression of IVp-II-regulated genes, and thus in a hypervesiculation phe-
notype. To examine the role of OMV production in adaptation to cell envelope stress, we com-
pared the survival of the four B. fragilis locked IVp-I/IVp-II mutants following contact with
antimicrobial compounds (bile, LL-37 and human defensins). The results indicated that the
ON/ON genotype was more resistant to bile, LL37 and certain types of human defensins than
the other three genotypes (Fig 8). Interestingly, we observed selective resistance against human
defensins. Among the defensins tested (human α-defensin 5 and human β-defensins 1, 2, and
3), a difference was observed only with human β-defensin 2, to which the ON/ON genotype
was most resistant. The survival rates after contact with the other defensins were similar
among the four locked mutants.
Fig 7. Effect of bile exposure on B. fragilisOMV formation. (A) Growth of B. fragilis YCH46 in GAM
supplemented with the indicated bile concentrations. (B) qPCR was used to determine the relative
abundance of the IVp-I-ON or IVp-II-ON genotypes after exposure to the indicated bile concentration. (C)
Effect of bile exposure on the expression of an IVp-I-regulated EPS production gene (BF2767) and IVp-II-
regulated membrane protein genes (BF3397 and BF3403). (D) OMV production of B. fragilis increased 7-fold
after exposure to 5% bile. (E) Schematic of the 3 x FLAG-tag fusion to the C-terminus of the BF3397-encoded
protein. (F) Enhancement of the BF3397-encoded membrane protein in response to 5% bile. A B. fragilis
YCH46 derivative with a 3 x FLAG-tag sequence fused to BF3397, as shown in panel E, was exposed to 5%
bile: the production of BF3397 was assessed byWestern blotting with an anti-FLAG antibody. Upper, middle,
and lower bands indicate the anti-FLAG tag antibody used for immunoprecipitation, BF3397 (unprocessed
form), and N-terminally processed BF3397 (indicated by arrowheads), respectively.
doi:10.1371/journal.pone.0148887.g007
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To test the protective effect of OMVs from bile, OMVs were purified from ON/ON mutant
culture. The purified OMVs were added to indicated concentration into the cell suspensions of
non-vesiculating mutant (OFF/ON or OFF/OFF), and the cells were exposed to 5% bile (S4
Fig). The survival rate of the cells was increased the OMV concentration was increased. The
survival rate of the cells with 50 μg/ml OMVs was significantly higher than the cells without
OMVs (p<0.01).
Genotypic prevalence of IVp-I/IVp-II in vivo
As shown in Fig 9A, in vitro growth of hypervesilating cells was equivalent to that of wild type
B. fragilis. The B. fragilis YCH46 wild-type strain was inoculated into three 8-week-old male
BALB/cA mice by gavage, and the fecal population levels of cells with IVp-I-ON or IVp-II-ON
genotypes were monitored by qPCR at 3, 7, 10, and 14 days after inoculation (Fig 9B). In the
cell suspension used for inoculation, the IVp-I-ON population was only 1.03±0.01%, whereas
the population of IVp-II-ON cells was 59.72±0.23%. After gut colonization, the fecal IVp-
I-ON population periodically increased, whereas IVp-II-ON population level remained stable
during the experimental period. This trend was similar to that for bile exposure shown in Fig
7B, indicating that IVp-I/IVp-II-regulated OMV production plays a role in B. fragilis adapta-
tion during gut colonization. However, the gut colonization until 14 days after inoculation was
not different among wild type and OFF/ON mutant strains (Fig 9C), indicating hypervesicula-
tion is one of the adaptation phenotypes under special condition.
Discussion
Some pathogenic bacteria have evolved phase-variation systems for cell surface structures to
evade host immunity (e.g., the flagella of Salmonella Typhimurium and the pili of Neisseria
meningitidis) [28–30]. Recent genomic analysis has revealed that phase-variation systems are
abundant among Bacteroides species, which are dominant members of the human gut micro-
biota. Bacteroides generate population heterogeneity among capsular polysaccharides [17, 21]
or in the SusC/SucD family of outer membrane proteins [18] by various mechanisms of DNA
Fig 8. Sensitivity of B. fragilis locked IVp-I/IVp-II-lockedmutants to antimicrobial substances.Mid-log
growth-phase mutant cells (ON/ON, OFF/ON, OFF/OFF, or ON/OFF) were suspended in PBS (107 cfu/ml)
and mixed with bile, LL-37 or defensins (human α-defensin 5 [HD-5], or human β-defensins-1 [HBD-1], -2
[HBD-2], or-3 [HBD-3]) at the indicated concentrations. After the mixtures were incubated at 37°C for 30 min
(for bile) or 1 h (for LL-37 and defensins), the surviving cells were enumerated. The columns show the ratios
of surviving cells to initial viable cell numbers. The data are expressed as the mean ± standard deviation. The
differences were statistically analyzed by ANOVA, followed by Tukey’s test. P-values of less than 0.05 and
0.01 are indicated as * and **, respectively.
doi:10.1371/journal.pone.0148887.g008
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inversion (simple promoter inversion or multiple shufflon-type DNA inversion). The results of
the present study included the novel observation that promoter inversion is a mechanism for
OMV formation in B. fragilis.
Because enhanced OMV production was observed only in the ON/ON genotype with
respect to IVp-I/IVp-II, and because IVp-II-regulated gene expression was specifically
increased in this mutant, an elevated outer membrane protein level driven by this gene cluster
was considered necessary for hypervesiculation. IVp-I was essential for the expression of the
downstream EPS biosynthesis genes, which confers a large capsule (LC) phenotype to B. fragilis
cells [20]. Patrick et al. initially described the LC phenotype in a population of cells surrounded
by a thick halo (recently recognized as EPS) after negative staining [31]. The EPS production
was reported to markedly increase in IVp-I-ON mutant with a single IR between IVp-I and the
first EPS gene [20]. The ON/ON mutants derived from YCH46 and NCTC9343 obtained in
this study have two and one IR between IVp-I and the first EPS gene, respectively (S1 Fig).
Because the ON/OFF genotype reduced OMV formation when compared with the ON/ON
genotype in both B. fragilis strain (Fig 3 and S2 Fig), EPS production is essential for OMV for-
mation but EPS overproduction may not be necessary for hypervesiculation.
Despite the variety of physiological and pathological roles of OMVs in Gram-negative bac-
teria [32, 33], the mechanism of OMV formation has remained a mystery. However, several
models of OMV formation have been proposed [33]: (i) decreased in lipoprotein linkage
between the outer membrane and peptidoglycan, (ii) increased membrane turgor pressure
reflecting the periplasmic accumulation of peptidoglycan components or misfolded proteins,
and (iii) charge repulsion resulting from a modified form of lipopolysaccharides. Similar to the
Fig 9. Comparative analysis of the in vitro and in vivo growth of IVp-I/IVp-II-lockedmutants. (A)
Competitive growth assay of ON/ON B. fragilismutant and its parental YCH46 stain in vitro. Equivalent cell
mixture of wild and mutant B. fragilis cells was inoculated into GAM broth. Closed circles indicate the
periodical change of total viable cell number in GAM broth. Columns indicate the relative abundance of the
wild and mutant B. fragilis cell in GAM broth. (B) IVp-I/IVp-II ON/OFF prevalence during in vivo gut
colonization IVp-I/IVp-II under in vivo gut colonization by B. fragilis. A cell suspension (7.0 x107 CFU in total)
of wild-type B. fragilis was inoculated into three 8-week-old male BALB/cA germ-free mice via gavage. At 3, 7,
10, and 14 days after inoculation, feces samples were collected. DNA was extracted from the initial inoculum
and the collected feces samples, and the ON/OFF ratio of IVp-I/IVp-II in each sample was determined by
qPCR. The data are expressed as means ± standard deviation. The bars labeled with different letters indicate
significant differences at p < 0.05. (C) Competitive growth assay of IVp-I/Vp-II-locked B. fragilismutant and its
parental YCH46 stain. Equivalent cell mixture of wild and the OFF/ONmutant cells was inoculated into BALB/
c germ-free mice. Colony PCR was performed on at least 96 colonies per sample with primer pair
encompassing the deletion site in BF2766 to compare population levels of mutants (closed triangles) with
wild type (closed circles) cells in the mouse intestine. In this experiment, mice were kept in a vinyl isolator to
maintain their gnotobiotic conditions.
doi:10.1371/journal.pone.0148887.g009
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first (i) OMV-forming mechanism described above, a hypervesiculation phenotype was
observed in Vibrio cholerae when the expression of the gene for the major outer membrane
protein, OmpA, was repressed through vrrA, a non-coding RNA [34]. In contrast, a study on
Salmonella Typhimurium reported the enrichment of an 18-kDa outer membrane protein,
PagC, in OMV: the overexpression of this protein provoked OMV formation [35]. Because
PagC is induced in acidified macrophage phagosomes [36], PagC-mediated OMVs might con-
tain molecules that modify the phagosomal environment making this habitat suitable for Sal-
monella. These results indicate that some pathogens possess machinery to actively produce
OMVs that modify the surrounding environment.
The mode of B. fragilisOMV formation demonstrated herein is similar to that of Salmo-
nella, because OMV formation is induced by overproduction of outer membrane proteins and
by environmental stress. The proteomic analysis revealed that the IVp-II-regulated outer mem-
brane protein, BF3397, localizes in both outer membrane and OMVs. It is noteworthy that
BF3397 protein was localized in OMV fraction as N-terminally processed form, which clearly
differed from that of outer membrane in size. It is important to know how BF3397 protein is
processed to elucidate the pinching off mechanism of OMV from outer membrane.
Pumbwe et al. reported that B. fragilis OMV formation is promoted by bile exposure [25].
In accord with those data, the results of the present study demonstrated that a hypervesiculat-
ing B. fragilis strain (ON/ON genotype) showed the most resistance to bile among the four
locked genotypes. Quantitative PCR showed that the IVp-I-ON population was increased
when B. fragilis was exposed to bile, whereas the ON/OFF ratio of IVp-II was not changed. The
FLAG-tag fused BF3397 protein level (both unprocessed and processed forms) was elevated
after bile exposure reflecting the enhancement of IVp-II activity through an increase in the
IVp-I-ON population (Fig 7F). The hypervesiculating strain was not only resistant to bile, but
it also showed greater resistance to certain types of human defensins. Defensins are cationic
antimicrobial peptides (CAMPS) that are produced by various cells as a component of innate
immunity. α-defensin 5 (HD5) and 6 (HD6) are the most common defensin molecules
expressed at the base of the crypts of Lieberkuhn [37]. Colonic epithelial cells constitutively
produce human β-defensin (HBD1). The expression of HBD-2, -3, and -4 is induced by various
inflammatory and bacterial stimuli [38].
As shown in Fig 8, the ON/ON genotype specifically showed resistance to HBD-2, whereas its
resistance to other human defensins (HD-5, and HBD-1, 3) was similar to that of the other three
genotypes. This result is interesting because HBD-2 is induced in the gut under inflammatory con-
ditions, such as in Crohn’s disease and ulcerative colitis [38]. Notably, no difference in the cell sur-
vival was observed with HD-5 and HBD-1. Therefore, OMV production via the coordinated
expression of IVp-I/IVp-II-regulated genes might be one of the defense mechanisms B. fragilis
uses to escape membrane stressors in the inflamed gut. This idea well explains the observation
that population of ON/ON genotype is very low in vitro culture or in feces from previously
reported healthy volunteers: six of seven tested was IVp-I was OFF orientation [20]. These find-
ings raised the idea that B. fragilis IVp-I-ON population level might be a good indicator for lower
gut inflammatory condition. Animal experiments demonstrated that the fraction of B. fragilis cells
with the IVp-I-ON genotype increased over time after gut colonization, thus indirectly indicating
an increase in the population with the ON/ON genotype. However, as shown in Fig 9C, coloniza-
tion ability to intact germ-free mice intestine was similar between wild and OFF/ONmutant B.
fragilis strains, These in vivo observation again supports the idea that the IVp-I/IVp-II-regulated
OMV phenotype is an adaptation to membrane stress encountered in the special setting.
How do these OMVs protect B. fragilis cells from membrane attack in the presence of bile
or human defensins? As shown in S4 Fig, exogenously added purified OMVs from ON/ON
cells protected OFF/ON and OFF/OFF mutant cells from bile stress dose-dependently. This
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finding suggests that OMVs act as decoys, making it more difficult for bile or defensins to
access B. fragilis cells. A recent proteomic analysis of B. fragilisOMVs showed that the vesicles
of this species are enriched with acidic proteins and that the OMV protein profile was
markedly different from that of the outer membrane [24]. This finding indicates the presence
of a selective sorting system that directs certain proteins to OMVs. Many of the acidic proteins
were glycosidases or proteases, thus suggesting a role for B. fragilis OMVs in nutrient uptake.
Curiously, the OMV-enriched proteome did not contain the IVp-II related proteins
(BF3397-BF3403). Comparative analysis of the protein profile in ON/ON mutant-derived
OMVs with that in previously reported B. fragilisOMVs [24] is expected to determine the role
of IVp-I/IVp-II-regulated hypervesiculating phenotype.
In conclusion, the present study provides the first identification of a genetic locus that is
involved in B. fragilisOMV formation. In addition, we demonstrated that B. fragilisOMV forma-
tion is uniquely regulated by phase-variable DNA inversions. In a variety of Gram-negative path-
ogens, OMVs have been recognized as an important vehicle for virulence factors or signaling
molecules. Despite the recent attention to OMV biology, the molecular basis of the OMV pro-
duction machinery and the specific sorting system for enriched proteins in OMVs remain elusive.
Although IVp-I/IVp-II-mediated vesicle formation might be only one mechanism of OMV pro-
duction in B. fragilis, localization and protein-protein interaction analyses of IVp-II-regulated
membrane proteins or IVp-I-controlled EPS may elucidate the precise mechanism of OMV pro-
duction. Furthermore, tracing the fate of B. fragilisOMVs or the OMV contents (enriched pro-
teins) in vivomay be facilitated by fluorescently labeling OMV-enriched proteins in the
hypervesiculating ON/ONmutant. The data presented herein may enhance OMV research in
this gut symbiont and provide new insights into human-microbe interactions via OMVs.
Materials and Methods
Bacterial strains and plasmids
The bacterial strains and plasmids used in the present study are listed in S3 Table. Escherichia
coliDH5α was used as a host strain for plasmid construction. The E. coli-Bacteroides shuttle plas-
mids pVAL-1 [39] and pLYL05 [40] were used for genetic manipulations in B. fragilis. A suicide
vector, pKK100 [18], was used to disrupt B. fragilis genes. E. coli strains were cultured in lysogeny
broth (LB) or on LB agar plates. B. fragilis strains were anaerobically grown in liquid Gifu Anaer-
obic Medium (GAM; Nissui Pharmaceutical Co., Tokyo, Japan) or on GAM agar plates using the
AnaeroPack System (Mitsubishi Gas Chemical Co., Inc., Tokyo, Japan) or in an anaerobic cham-
ber conditioned with mixed gases (N2, 80%; CO2, 10%; and H2, 10%). When necessary, antibiot-
ics were added to the media at the following concentrations: ampicillin (Amp), 50 μg/ml;
cefoxitin (Cfx), 50μg/ml; erythromycin (Em), 10 μg/ml; and tetracycline (Tc), 10 μg/ml. To com-
pare the cell sedimentation rate among BF2766 B. fragilismutants, overnight cultures were stati-
cally maintained at room temperature in an anaerobic chamber. In competitive growth assay,
equivalent number (3.6 x 109 colony-forming unit/ml each) of wild and ON/ONmutant B. fragi-
lis YCH46 cell was mixed, and the mixture was added to 1% into 10 ml of GAM broth. A part of
the culture was periodically sampled and appropriate dilutions were plated onto GAM agar
plates. Colony PCR was performed on at least 96 colonies per sample with primer pair encom-
passing the deletion site in BF2766 to determine the ratio of wild type and ON/ONmutant cells.
Gene disruption and site-directed mutagenesis of B. fragilis
The target genes of B. fragilis YCH46 were disrupted as previously described [18]. First, 2-kb
DNA fragments downstream and upstream of the target region were separately amplified and
fused using a second PCR reaction via overlapping sequences that were incorporated into the
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primer sequences. The fused DNA fragments were then cloned into pKK100. The purified plas-
mid was subsequently introduced into B. fragilis by electroporation as previously described
[41, 42], employing conditions of 2.5 kV, 25 μF, and 200 O. Em-resistant colonies, in which the
target plasmid had integrated into the chromosome through a single genetic crossover, were
selected and grown in non-selective GAM broth. Dilutions of the overnight culture were spread
onto GAM agar plates to provide an appropriate colony number; the plates were then replica
plated onto GAM and GAM/Em plates to screen for Em-sensitive clones that resolved the
diploid through a second homologous recombination. The expected mutants and revertants
were discriminated by PCR using primers flanking the deletion site. In the case of B. fragilis
NCTC9343, the fusion PCR products were first cloned into pLYL05 and subsequently intro-
duced into the strain by electroporation to modify the plasmid by using a host cell restriction/
modification system. After the plasmid was purified from B. fragilis NCTC9343, the XbaI frag-
ment containing a replication protein gene for Bacteroides was removed by restriction diges-
tion. The remaining fragment (which could not replicate in Bacteroides) was re-ligated and
electroporated into B. fragilis NCTC9343 to integrate it into the target site. Cfx-resistant colo-
nies were selected and replica plated to obtain the expected deletion mutants as described for
strain YCH46. Gene replacement for site-detected mutagenesis was performed according to
the process described above. The primer sequences used for gene disruption and replacement
are listed in S4 Table. Synthetic oligonucleotide primers were purchased from Sigma-Aldrich
Japan Co., Ltd. (Tokyo, Japan). DNA sequencing was performed on an ABI PRISM 3100
Genetic Analyzer (Applied Biosystems) by using the ABI PRISM BigDye Terminator Cycle
Sequencing Ready Reaction Kit, version 1.1 (Applied Biosystems).
Promoter inversion assay
The orientations of the IVp-I and IVp-II promoters relative to their downstream genes were
assessed by PCR as previously described [22]. As shown in Fig 1C, the PCR primers F and R
were designed outside of the IRs and primer M was designed from the region between the IRs.
Two amplification reactions were set up for each promoter region: one was conducted with prim-
ers F andM (to detect promoters in the ON orientation) and the other was conducted with R
andM (to detect promoters in the OFF orientation). PCR was performed under the following
conditions: preheating at 95°C for 1 min, followed by 35 cycles of denaturation at 95°C for 30 s,
annealing at 55°C for 30 s, and extension at 72°C for 1 min, with a final extension at 72°C for
5 min. The PCR products were visualized by ethidium bromide staining after electrophoresis on
a 2% agarose gel. To examine the bile stress response, quantitative real-time PCR analyses were
performed using genomic DNA to compare the ON/OFF ratios of the IVp-I or IVp-II promoters.
Briefly, B. fragilis cells were grown anaerobically in GAM broth with 0%, 1% or 5% bile (Wako
Chemical Co. Ltd., Tokyo) at 37°C for 8 h. The cells were harvested, and genomic DNA was
extracted using the Easy-DNA Kit (Invitrogen). Quantitative PCR analyses were performed
using SYBR Premix Ex Taq II (Takara) under the following conditions: preheating at 95°C for
30 s, followed by 40 cycles of denaturation at 95°C for 15 s, annealing at 55°C for 30 s, and exten-
sion at 60°C for 34 s in an ABI PRISM 7500 (Applied Biosystems). Genomic DNA from the
BF2766 mutant (IVp-I/IVp-II ON/ON genotype) was used as the quantification standard. The
rpoD gene was amplified to normalize the individual DNA samples. The oligonucleotide
sequences of the primers used for each target gene are listed in S4 Table.
RNA isolation and quantitative real-time PCR
Total RNA was extracted from mid-logarithmic-phase cultures (OD660; 0.4–0.6) of B. fragilis
strains using the hot-phenol method [43]. The RNA was further purified using the RNeasy
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CleanUp Kit (Qiagen) and was treated with TURBO DNA-free (Ambion) to remove contami-
nating DNA. The total RNA was reverse transcribed using a PrimeScript RT reagent Kit
(Takara Shuzo Co., Ltd., Otsu, Japan) with random hexamers at 37°C for 15 min. Reverse tran-
scription was terminated by heating the mixtures at 85°C for 5 sec. The cDNA products were
subsequently amplified using SYBR Premix Ex Taq II (Takara) under the following conditions:
preheating at 95°C for 10 s, followed by 40 cycles of 95°C for 5 s and 60°C for 34 s in an ABI
PRISM 7500 (Applied Biosystems). All samples were run in triplicate. Threshold cycle values
were normalized to the levels of rpoD transcripts, and changes were calculated using the 2-ΔΔCT
method [44]. The oligonucleotide sequences of the primers used for each target gene are listed
in S4 Table.
Electron microscopy
Cultures from the four B. fragilis IVp-I/IVp-II promoter genotypes with BF2766 deletions were
fixed overnight with 2% glutaraldehyde in PBS at 4°C. For scanning electron microscopy
(SEM), each cell sample was dehydrated with a series of ethanol solutions ranging in 10%
increments from 50% (vol/vol) ethanol in distilled water to absolute ethanol. All samples were
dried to the critical point using a critical point dryer, coated with gold, and examined by SEM
(Hitachi S-800; Hitachi, Tokyo, Japan). For transmission electron microscopy (TEM), the fixed
cells were pelleted by centrifugation at 3,000 x g for 10 min. Each sample of cells was fixed over-
night in 1% osmic tetroxide. The specimens were dehydrated in acetone and embedded in
epoxy resin (EMbed 812). The embedded materials were sectioned with a diamond knife on an
LKB ultramicrotome and were stained with uranyl acetate and lead citrate. The stained sections
were mounted on copper grids and observed in a Hitachi electron microscope H-700 at 75 kV.
DNAmicroarray
The B. fragilis YCH46 DNA microarray from NimbleGen Systems, which includes 4,527 target
genes with at least 8 unique 60-mer synthetic oligonucleotide probes for each gene, was used
for the comparative transcriptomic analysis of the mutant strains. The cDNA synthesis,
hybridization, and scanning were performed at NimbleGen. The microarray data were ana-
lyzed by quantile normalization and robust multiarray averaging [45]. The normalized data
were processed with ArrayStar software (DNASTAR). The samples were filtered to identify dif-
ferential expression that showed>4-fold induction in the ON/ON (IVp-I/IVp-II promoters)
genetic background. Student’s t test was used for the analyzing the mean log ratios of two sam-
ples, and Bonferroni’s adjustment for multiple testing was applied, as rigorous criteria for sig-
nificant changes in signal intensity. Changes with a p-value of less than 0.05 (p< 0.05) were
considered statistically significant.
Quantification of OMVs
The amount of OMVs produced by B. fragilis cells was monitored based on the protein concen-
trations in the culture supernatant as previously reported [46]. Briefly, B. fragilis cells were
anaerobically cultured in 10 ml of GAM broth at 37°C for 12 h. In case of large scale OMVs
purification, cells were cultured in 50–1,000 ml of defined minimal medium (DMM) [47] at
37°C for 24 h. The cultures were subsequently centrifuged at 6,000 x g for 10 min at 4°C, and
the supernatants were filtered through 0.45-μm pore-size filters. The filtrate was subjected to
ultracentrifugation at 150,000 x g for 3 h at 4°C. The pellets were washed three times with phos-
phate-buffered saline (PBS) and resuspended in 200 μl of PBS. Protein concentrations were
measured using the Bradford method [48].
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FLAG tag fusion andWestern blotting
To evaluate the effect of IVp-II promoter orientation on the expression of the downstream
gene (BF3397), the amount of intracellular FLAG-tagged BF3397-encoded protein was moni-
tored. First, BF3397 was fused to a 3 x FLAG tag-encoding sequence at the 3’ end by using
PCR. The obtained product was cloned into pKK100. The constructed plasmid was integrated
into the B. fragilis chromosome, and the original BF3397 gene was replaced with the BF3397-3
x FLAG tag fusion gene by homologous recombination. Immunoprecipitation andWestern
blotting were performed on the B. fragilis cells with or without exposure to 5% bile (Wako
Chemical Co. Ltd., Tokyo) in GAM broth. The cells were harvested following 12-h of incuba-
tion in media and were subsequently resuspended in PBS supplemented with an EDTA-free
complete protease inhibitor cocktail (Roche). After disrupting the cells by sonication and sub-
sequent centrifugation (13,000 x g for 20 min), the supernatants (S13) were used for immuno-
precipitation. One microgram of mouse anti-FLAGM2 antibody (Sigma) was added to S13
(70 μg protein), and the mixtures were incubated with rotation for 12 h at 4°C. After the addi-
tion of Dynabeads protein G (25 μl; Invitrogen), the mixture was further incubated for 2 h. The
Dynabeads were washed 4 times in PBS and eluted by boiling with SDS-PAGE loading buffer
for 5 min. Aliquots (20 μl) of the samples were loaded onto 10% SDS-PAGE gels, and the sepa-
rated protein bands were transferred to a PVDF membrane using a Mini Trans-blot cell (Bio-
Rad). The membrane was blocked with SuperBlock Blocking Buffer (Thermo) overnight at
4°C, reacted with mouse anti-FLAGM2 antibody for 30 min at room temperature, and subse-
quently incubated with horseradish peroxidase-linked secondary antibody (anti-mouse IgG)
for 1 h at room temperature. Antibody binding was visualized with ECL Plus detection reagent
(GE) and X-ray film.
Preparation of outer membrane protein
Outer membrane protein purification was performed as follows. The overnight culture (50 ml)
of FLAG-tagged strain (TSRM2766ON/ON BF3397::FLAG) in DMM broth were pelleted
(6,000 x g for 10 min), and resuspended in 50 mM Tris-HCl (pH8.0), 150 mM NaCl, 50 mM
MgCl2 containing EDTA-free complete protease inhibitor cocktail (Roche). After disrupting
the cells by sonication, cell debris was removed by centrifugation at 6,000 x g for 10 min at 4°C,
and the supernatant was further fractionated to cytoplasmic fraction (supernatant) and mem-
brane fraction (pellet) by ultracentrifugation at 100,000 x g for 1 h at 4°C. The pellet was
washed twice with 50 mM Tris-HCl (pH8.0), 150 mM NaCl, 50 mMMgCl2 containing EDTA-
free complete protease inhibitor cocktail, resuspended in the same buffer containing 1.5% (v/v)
Triton X-100 and then incubated at 25°C for 1 h. The outer membrane fractions were recov-
ered by centrifugation at 100,000 x g for 1 h at 4°C.
Assessment of resistance to bile and human antimicrobial peptides
B. fragilis cells were anaerobically grown in GAM broth overnight at 37°C. An aliquot of cul-
ture (30 μl) was inoculated into 3 ml of fresh GAM broth and cultured until late-log phase
(OD600:1.3–1.6). After harvesting and washing with PBS, the cells were resuspended in PBS
and subsequently treated with 5% bile (Wako), 0.5 μM LL-37 (Anaspec), or human defensins
(10 μM α-defensin 5, 10 μM β-defensin 1, 10 μM β-defensin 2, or 0.5 μM β-defensin 3; all pur-
chased from Peptide Institute, Japan). After the suspensions were incubated at 37°C, the viable
cells numbers were measured periodically by plating 0.1 ml of the suspensions on GAM agar
plates. The survival rate was calculated from the ratios of viable cells in the suspensions con-
taining bile, LL-37, or human defensins to those in the suspensions without antimicrobial
substances.
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Protection assay with OMVs
We determined whether the purified OMVs from the ON/ONmutant could protect the non-
vesiculating cells (OFF/ON or OFF/OFF mutants) from bile stress. In briefly, the ON/ONmutant-
derived OMVs (10 or 50 μg/ml of final concentration) or PBS was added to non-vesiculating cell
suspensions. After the suspensions were treated with 5% bile at 37°C for 30 min, the viable cells
counts were measured periodically by standard plating assay with GAM agar plates. The survival
rate was calculated from the viable cell counts in samples with/without exposure to 5% bile.
Intestinal colonization assay in germ-free mice
Three male germ-free BALB/cA mice (8 weeks old, Clea Japan Inc.) were orally inoculated
with a suspension of wild-type B. fragilis YCH46 (7.9 x 107 colony-forming units). Fecal sam-
ples were collected 3, 7, 10, and 14 days after inoculation. DNA was purified from the inoculum
and from the fecal samples. ON/OFF ratio with respect to IVp-I or IVp-II in each sample was
determined by qPCR.
Competitive colonization assay of wild type and OFF/ON mutant B. fragilis YCH46 was
performed by orally inoculating the mixture of equivalent number of each type of cells (2.3 x
108 colony-forming units) to five male germ-free BALB/cA mice (8 weeks old, Clea Japan).
Fecal samples were collected at 3, 7, 10, and 14 days after inoculation, and appropriate dilutions
of the samples were prepared and spread on GAM agar plates. Colony PCR was performed on
at least 96 colonies per sample with primer pair encompassing the deletion site in BF2766 to
compare population levels of mutants with wild type cells in the mouse intestine. In this experi-
ment, mice were kept in a vinyl isolator to maintain their gnotobiotic condition.
Microarray accession numbers
The microarray data have been deposited in the Gene Expression Omnibus database (www.
ncbi.hlm.nih.gov/projects/geo) under the following accession numbers: normalized data,
GSE69071; platform, GPL13213; and raw data files, GSM1692522 to GSM1692525.
Ethics
Animal experiment was carried out in accordance with Japanese legislation (Act on Welfare
and Management of Animals, 1973, revised in 2012) and guidelines under the jurisdiction of
the Ministry of Education, Culture, Sports, Science and Technology, Japan (Fundamental
Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic
Research Institutions, 2006). The protocols of animal experiments were approved by the com-
mittee of animal experiment of the Tokushima University (Assurance Number; 08181). Ani-
mal care, housing, feeding, sampling, observation, and environmental enrichment were
performed in accordance with the guidelines.
Supporting Information
S1 Fig. Schematic map of the IVp-I region in ON/ONmutant of YCH46 (A) and
NCTC9343 (B). IR indicates the inverted repeat sequence. IRs (indicated as IR2) are shown by
bold letters.
(TIFF)
S2 Fig. SEM observation of IVp-I/IVp-II-locked B. fragilismutants. (A) SEM observation of
the ON/ON mutants of YCH46 (upper panel) and NCTC9343 (lower panel) at high magnifica-
tion (x 30,000). The ON/ON mutant of NCTC9343 was constructed after disrupting the
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BF2694 gene, reported as tsr19. (B) SEM observation of the four combinations of NCTC9343
locked mutants with respect to IVp-I/IVp-II orientation (x 13,000). Only the ON/ON mutant
showed the hypervesiculation phenotype similar to YCH46.
(TIF)
S3 Fig. EPS production is necessary for OMV formation in B. fragilis. BF2769, which
encodes a tyrosine protein kinase, was deleted from the ON/ON mutant. BF2771, which is
located outside the EPS locus and is independent of IVp-I, was also deleted. SEM examination
was performed on these mutants. The BF2769 deletion abrogated the hypervesiculation pheno-
type, whereas the BF2771 deletion had no effect on OMV formation. Plasmid complementa-
tion of BF2769 restored hypervesiculation. The bars indicate 1 μm.
(TIF)
S4 Fig. Protection of non-vesiculating cells from the bile stress by exogenously added
OMVs. The OMVs purified from ON/ON cell culture (final concentration of 10 μg/ml or
50 μg/ml) or PBS (pH7.4) were added to the mid-log-phase OFF/ON and OFF/OFF mutant
cell suspensions. These suspensions were treated with 5% bile. After 30-min incubation at
37°C, the surviving B. fragilis cells were enumerated by standard plate culture. The columns
show the ratios of surviving cells to the initial viable cell counts. The data are expressed as the
mean ± standard deviation. The differences were statistically analyzed by ANOVA, followed by
Tukey’s test. The p-values of less than 0.01 are indicated by asterisks ().
(TIF)
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